# Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Canonical URL: https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-third-quarter-2025-financial-results-and-provides-corporate-update
Ticker: LQDA
Company: Liquidia Corporation
Source: Liquidia Corporation
Published: 2025-11-03 11:30 EST
Original Source URL: https://www.liquidia.com
## Summary

Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continues Achieved profitability in the first full quarter of YUTREPIA sales More than 2,000 unique patient prescriptions and 1,500 patient starts to date Company to host webcast today at 8:30 a.m. ET MORRISVILLE, N.C.

## Article Body
Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continues Achieved profitability in the first full quarter of YUTREPIA sales More than 2,000 unique patient prescriptions and 1,500 patient starts to date Company to host webcast today at 8:30 a.m. ET MORRISVILLE, N.C.
## Recent Company News
- 2026-05-27 12:30 EST — [Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference) — Source: Liquidia Corporation
- 2026-05-11 10:30 EST — [Liquidia Corporation Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-first-quarter-2026-financial-results) — Source: Liquidia Corporation
- 2026-05-06 12:30 EST — [Liquidia Corporation to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-participate-in-upcoming-investor-conferences) — Source: Liquidia Corporation
- 2026-05-04 12:30 EST — [Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026](https://biopharmsignal.com/news/LQDA/liquidia-corporation-to-report-first-quarter-2026-financial-results-on-may-11-2026) — Source: Liquidia Corporation
- 2026-03-05 11:30 EST — [Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/LQDA/liquidia-corporation-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update) — Source: Liquidia Corporation
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)